Impact News +++ Corsair Gaming Stock Takes Off After Unveiling New AI Products. Should You Buy Into the Rally? (Fool) +++ CORSAIR Aktie -4,69%

ELI LILLY Aktie

>ELI LILLY Aktienkurs

969.8 EUR +4.0% (TradegateBSX)

Ask: 969.4 EUR / 10 Stück

Bid: 966.7 EUR / 10 Stück

Tagesumsatz: 4501 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ELI LILLY Aktie über LYNX handeln

Intraday

1 Jahr

>ELI LILLY Performance

1 Woche: +6,7%

1 Monat: +26,2%

3 Monate: +5,0%

6 Monate: -1,3%

1 Jahr: +46,3%

laufendes Jahr: +1,8%

>ELI LILLY Aktie

Name:

ELI LILLY

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US5324571083 / 858560

Symbol/ Ticker:

LLY (Frankfurt) / LLY (NYSE)

Kürzel:

FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY

Index:

S&P500

Webseite:

https://www.lilly.com/

Profil:

Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, on..
>Volltext..

Marktkapitalisierung:

861689.25 Mio. EUR

Unternehmenswert:

894652.76 Mio. EUR

Umsatz:

62073.22 Mio. EUR

EBITDA:

31113.37 Mio. EUR

Nettogewinn:

21715.04 Mio. EUR

Gewinn je Aktie:

23.9 EUR

Schulden:

37261.37 Mio. EUR

Liquide Mittel:

4412.6 Mio. EUR

Operativer Cashflow:

Bargeldquote:

0.14

Umsatzwachstum:

38.06%

Gewinnwachstum:

113.09%

Dividende je Aktie:

5.52 EUR

Dividendenrendite:

0.58%

Dividendenschätzung:

0.64%

Div. Historie:

15.05.26 - 1.4872811€
13.02.26 - 1.457352€

>weitere anzeigen...

Insiderhandel:

1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 15.754.537 USD.

Suchwörter:

ELI LILLY, LILLY DEUTSCHLAND

Letzte Datenerhebung:

28.05.26

>ELI LILLY Kennzahlen

Aktien/ Unternehmen:

Aktien: 941.74 Mio. St.

Frei handelbar: 89.96%

Leerverk. Aktien: 0.9%

Rückkaufquote: 0.52%

Mitarbeiter: 50000

Umsatz/Mitarb.: 1.12 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 16.22%

Bewertung:

KGV: 38.59

KGV lG: 29.59

KUV: 13.3

KBV: 32.42

PEG-Ratio: 0.3

EV/EBITDA: 28.75

Rentabilität:

Bruttomarge: 82.83%

Gewinnmarge: 34.98%

Operative Marge: 47.3%

Managementeffizenz:

Gesamtkaprendite: 24.54%

Eigenkaprendite: 107.64%

>ELI LILLY Anleihen

>ELI LILLY Peer Group

Gesundheit, Neurologische Erkrankungen/ Schlaganfälle, Hauterkrankungen & -behandlung/ Dermatologie, Stoffwechselerkrankungen (Diabetes/ Adipositas), Autoimmunerkrankungen
>Alle Branchen..

>ELI LILLY Chart & Kurs - NYSE

>ELI LILLY News

28.05.26 - 19:36	Why Is Eli Lilly Stock Surging On Thursday? (Benzinga)
	Eli Lilly (NYSE:LLY) shares jumped on Thursday morning after securing expanded PBM coverage for its blockbuster obesity treatments, Zepbound and Foundayo. Importance Rank: 1 read more...

28.05.26 - 18:48	Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now (Fool)
	Novo Nordisk lost its lead in the GLP-1 race, but Eli Lilly's valuation is a bit rich....

28.05.26 - 18:30	Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic and Mounjaro (PR Newswire)
	Parker Waichman, a national law firm, has now filed multiple lawsuits where each Plaintiff alleges that he or she developed NAION after taking Novo Nordisk's Ozempic or Wegovy and/or Eli Lilly's Mounjaro or Zepbound. PORT WASHINGTON, N.Y., May 28, 2026 /PRNewswire/ -- Parker Waichman has......

28.05.26 - 16:31	Eli Lilly Aktie im Aufwind: Wichtige Kostenzusage und positive Nachrichten beflügeln Kurs (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

28.05.26 - 14:24	Is Eli Lilly Stock Outperforming the Nasdaq? (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

28.05.26 - 14:03	Eli Lilly-Aktie legt zu: CVS nimmt Adipositas-Medikament Zepbound in Erstattungsliste auf (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

28.05.26 - 13:06	CVS Returns Zepbound to Drug Plans After Lilly Slashes Price (Bloomberg)
	More than 10 million US patients will regain easy access to Eli Lilly & Co.'s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for certain drug plans....

28.05.26 - 12:48	Foundayo and Zepbound now covered for millions of Americans (PR Newswire)
	CVS Caremark begins covering Foundayo June 1 and resumes Zepbound coverage by October 1 Eligible patients may pay as low as $25 a month for their medicine INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an access milestone in obesity care: all......

28.05.26 - 06:01	Lilly Vows Global Drug Launches Despite Pricing Pressure (Bloomberg)
	Eli Lilly & Co. said it will press ahead with global drug launches despite uncertainty over the Trump administration's Most-Favored-Nation (MFN) pricing proposal, pushing back on concerns that the policy could deter rollouts in lower-priced markets such as Japan....

28.05.26 - 00:15	Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion (Zacks)
	Eli Lilly (LLY) stock has surged to new record highs of over $1,000 a share, cementing its position as one of the market's most dominant growth stories and the first pharmaceutical firm worth $1 trillion....

27.05.26 - 22:36	Novo Nordisk Is Beating Eli Lilly in the Obesity Pill Market. Should Lilly Investors Be Worried? (Fool)
	There is no reason to panic just yet....

27.05.26 - 20:54	The $4 Billion Reason Eli Lilly Stock Is Up Today (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

27.05.26 - 20:36	Lilly Goes on $20B Buying Spree as It Seeks Next Act (Bloomberg)
	Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly is on a record spending spree, announcing acquisitions worth more than $20 billion so far in 2026 as the drugmaker expands beyond its blockbuster obesity franchise. (Source: Bloomberg)...

27.05.26 - 20:36	President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too? (Fool)
	Eli Lilly's fundamentals matter more than Trump's stock purchases....

27.05.26 - 20:30	Eli Lilly to Expand Vaccine Pipeline With Three Biotech Buyouts (Zacks)
	LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes....

27.05.26 - 17:30	Here′s Why Eli Lilly (LLY) is a Strong Momentum Stock (Zacks)
	The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

27.05.26 - 17:18	Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire)
	INDIANAPOLIS, May 27, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health, will take part in a fireside......

27.05.26 - 17:00	Healthy Returns: Eli Lilly makes a new push into vaccines – here′s what to know (CNBC)
	The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined....

27.05.26 - 10:45	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer (Zacks)
	Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer are benefiting from innovation, pipeline growth and strong demand in key therapies....

27.05.26 - 10:15	Micron Was Worth Less Than $70 Billion Last Year—Now It′s A $1 Trillion Company, Overtaking JPMorgan, Walmart And Eli Lilly (Benzinga)
	Micron Technology joins the $1 trillion club after a historic 19% stock surge. Discover how it overtook giants JPMorgan, Walmart, and Intel. Importance Rank: 1 read more...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Geschrei macht den Wolf größer als er ist. - Sprichwort Deutschland

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram